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Although there are a number of injectable biomaterials currently under development, they present some drawbacks
such as being based on synthetic polymers, needing toxic or aggressive synthesis procedures or using raw materials
with low availability and/or high production costs. Having this in mind, a novel injectable biomaterial using
chitooligosaccharides as starting materials was developed. This system uses a widely available and cheap polymer
from marine biomass (chitosan), which can be turned into an injectable material by water-based and ecologically
friendly reactions. Chitooligosaccharides were functionalized with methacrylic groups, to allow in situ cross-
linking. The degree of substitution, as determined by 1H NMR, varied between 5 and 50%. The system was
characterized in terms of kinetics of gel formation, rheology, degradation behavior and in vitro cytotoxicity. The
gelation time could be easily tailored between 1.5 and 60 min by changing the conditions of the methacrylation
reaction, and the final gel presented rheological properties typical of strong gels, that is, shear stresses in the kPa
range. The cross-linked gel was degradable and nontoxic, presenting indeed an interesting cytokinetic effect.
Injectable materials based on chitooligosaccharides are, therefore, an innovative system combining adequate
biological performance, ease of preparation, and an ecologically friendly concept of production.
Introduction
Injectable systems are an important class of materials
employed in the biomedical field. Besides the long-term use of
acrylic polymers or calcium-phosphate ceramics as bone ce-
ments, recently injectable materials made of biodegradable
polymers have drawn considerable attention. The potential
applications of injectable biodegradable systems (IBS) are
mainly as tissue engineering scaffolds or controlled drug delivery
systems. Injectable materials eliminate the need of complicated
surgery for implantation and are able to take the exact shape of
the defect to be regenerated, thus eliminating the need for precise
prefabrication of the scaffold. Moreover, they may be easily
mixed with cells, growth factors, or drugs just before implanta-
tion, making the handling of such agents much easier. Depend-
ing on the composition and hardening mechanism of the
injectable material, both hard and soft tissues may be targeted.
In general, in situ cross-linking systems lead to stiffer and
stronger materials; thermoresponsive hydrogels or self-assembly
systems, on the other hand, are weaker, although they raise less
cytotoxicity issues due to the lack of solvents or initiators.1,2
In recent years, the attention has moved from the traditional,
nondegradable injectable materials such as poly(isopropylacry-
lamide) (PNIPA) or Pluronics to the more appealing degradable
counterparts.3-5 The latter includes di-, tri-, or multiblock
copolymers of poly(lactic-co-glycolic acid) (PLGA) and poly-
(ethylene glycol) (PEG)6,7 and cross-linkable systems of acry-
lated poly(propylene fumarate) (PPF)8,9 or poly(anhydrides),10,11
among other synthetic polymers. Although these and other
polymers have fulfilled all the requirements for being used as
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injectable materials in tissue engineering and drug delivery
applications, their synthesis is time-consuming and costly and
makes use of toxic solvents or substances, with a consequent
need for purification steps. To counteract that, natural polymers,
specially chitosan, alginate and gelatin, have also been employed
in the preparation of injectable biomaterials.4,5 In most cases,
however, the thermogelling effect is only obtained when high
amounts of a synthetic polymer such as PNIPA or Pluronics
are grafted on the biopolymer backbone.12-14 Such methodology
eliminates the biobased appeal of these systems once they are
more like natural-“containing” than natural-“based” polymers.
In this context, an innovative natural-based IBS was devel-
oped. This system is mainly constituted by biobased materials,
and a “green” chemistry approach is used throughout the
fabrication process. To that, chitooligosaccharides (“oligomers”
of chitosan) were used as the precursor, and a simple meth-
acrylation reaction was employed to incorporate polymerizable
double bonds to the oligomers. In this communication the
synthesis and in vitro characterization of such systems are
reported.
Experimental Section
Materials and Reagents. Chitosan from crab shells (85% deacety-
lated, Mv ) 640 kDa, 97% pure) was obtained from Idebio S. L., Spain.
The pectinase for depolymerization was Multifect Pectinase FE, from
Genencor International B. V. (The Netherlands), with an activity of
180 U/g. All other reagents and solvents (acetic acid, methacrylic
anhydride, sodium persulfate, ascorbic acid) were reagent grade and
used as received. Phosphate buffered saline (PBS) was prepared by
dissolving one pouch (Sigma-Aldrich) in 1 L of distilled water.
Preparation of Methacrylated Chitooligosaccharides. Chitosan
was first purified by dissolution in diluted acetic acid and reprecipitation
in aqueous sodium hydroxide. It was then washed several times and
freeze-dried for further use.
Depolymerization was performed in acetate buffer (acetic acid/
sodium hydroxide, pH 5.5). After preliminary tests to define the
optimum conditions of temperature, time, agitation, and ratio of enzyme,
these were defined as 50 °C, 17 h, 60 rpm, and 1 g of enzyme per
100 g of chitosan, respectively. After the depolymerization step, the
solution was heated at 100 °C for 10 min and filtered (to denature and
remove the enzyme), precipitated in 90% ethanol and centrifuged (to
remove low molecular weight oligomers). The oligomers were then
redissolved in water, washed in 90% ethanol, and centrifuged three
more times (to ensure complete removal of acid and sodium hydroxide)
before being vacuum-dried.
Methacrylation of chitooligosaccharides was performed in PBS under
different conditions: (a) time, from 15 to 45 min; (b) temperature, from
25 to 50 °C; (c) concentration of oligomer in PBS, from 2.5 to 7.5%;
(d) molar ratio of methacrylic anhydride per NH2 groups in chitosan,
from 0.125 to 0.268. The different conditions yielded different degrees
of substitution on chitooligosaccharides (see Results and Discussion).
After preliminary tests and optimization using factorial planning, the
standard conditions used to obtain samples for characterization studies
were 50 °C, 15 min, 2.5% of oligomer in PBS (w/v), and molar ratio
of 0.268.
Analysis of Modified Chitooligosaccharides. Matrix-assisted laser
desorption ionization/time-of-flight mass spectrometry (MALDI-TOF/
MS) was performed on a Voyager-DE PRO equipment (Applied
Biosystems) using 2,5-dihydroxybenzoic acid as the matrix. The
oligomer was dissolved (1% wt/vol) in 0.175 M acetic acid. Mass
spectra were recorded in the positive ion mode using a nitrogen laser
(337 nm). All spectra were measured in the linear mode.
Proton nuclear magnetic resonance (1H NMR) was performed by
dissolving oligomers in deuterium chloride (35 wt %, Aldrich)/
deuterium oxide (99.9%, Merck). Spectra were acquired with a Inova
400 MHz equipment (Varian), at 60 °C, with a relaxation delay of 6 s
and 45° pulses. The degree of deacetylation was calculated according
to ref 15
DDA(%)) ( H1(D)H1(D)+CH3(A) ⁄ 3) × 100
Analogously, degrees of substitution were calculated as
DS(%)) ( CH3(M) ⁄ 3H1(D)+CH3(A) ⁄ 3+CH3(M) ⁄ 3) × 100
where H1(D) corresponds to the integral of the peak of the first proton
of the glucosamine unit, CH3(A) to the peak of the methyl group of
N-acetyl glucosamine, and CH3(M) to the peak of the methyl group of
N-methacrylamide glucosamine. Standard methacrylation conditions
described in the previous section yielded oligomers with DS of 19%,
and these were the samples used for characterization studies.
Analysis of the Polymerization Process. For gelation time and
temperature for the tube inversion method (TIM), methacrylated
chitooligosaccharides (10% wt/vol) and ascorbic acid (0.025 M) were
dissolved in PBS and equilibrated at 37 °C; then a solution of 20%
(wt/vol) of sodium persulfate in PBS was added to yield a final
concentration of 0.062 M in the oligomer solution. Each 30 s, the tube
was removed from the water bath and inverted; the time at which no
flow was observed was considered as the gelling time. For determining
the maximum temperature of polymerization, a thermocouple with
digital display was immersed in the solution at 37 °C before the addition
of the persulfate. Temperature was acquired each 20 s for 15 min.
For polymerization studies in NMR, the pH of the solution was
adjusted with sodium deuteroxide (40% in D2O, Alfa Aesar), and
temperature of acquisition was changed to 37 °C. A first spectra was
recorded without the initiator redox pair to equilibrate the sample and
adjust equipment parameters; then the redox pair was added and mixed,
and the tube was immediately inserted in the magnet to record the
double bond conversion.
For oscillatory rheometry, the oligomer solution containing AA
(0.025 M) in PBS was inserted between the parallel plates (40 mm) of
an Advanced Rheometer 1000 (TA Instruments), and the temperature
was adjusted to 37 °C. Next, the solution of NaPS was added and time
sweep measurements were started with the following conditions:
frequency of 1 rad/s, oscillation stress of 0.4 Pa, and plates gap of 1
mm. For frequency sweep tests, frequency was varied between 0.75
Hz and 2.50 Hz and oscillation strain was fixed at 0.10 (up to 17.5
min) and 0.01 (afterward) to ensure linear viscoelasticity throughout
the experiment. Gel time was defined as the time when tan δ was
independent of the frequency when plotted against polymerization time.
In Vitro Evaluation of Cytotoxicity and Degradation. Degradation
tests were performed by immersing cylindrical specimens of injectable
materials in PBS supplemented with 2 U/mL of lysozyme immediately
after polymerization. A ratio of 2.78 mL of PBS per 1 g of injectable
oligomer was employed for all specimens. Chitosan membranes were
used as controls under the same conditions. To avoid accounting for
unpolymerized oligomers and soluble activators on the degradation
studies, both cylinders and membranes were washed for 2 h in PBS at
37 °C. At several periods up to 4 weeks, aliquots of the solution were
removed and fresh solution was added to keep volume and enzyme
concentration constant. At 7, 9, and 11 weeks, the whole solution was
changed. Degradation solutions were subjected to high-pressure liquid
chromatography (HPLC) analysis in a Shimadzu LC-20AD equipment,
using a Phenomenex Luna-NH2 column in reversed mode. Mobile phase
was PBS, flow rate was 1 mL/min, column temperature was 40 °C,
and a volume of 100 µL was injected. The chromatograms for each
specimen were compared with standards of glucosamine, N-acetyl
glucosamine, PBS with lysozyme, pristine chitooligosaccharides, and
methacrylated oligosaccharides to identify the eluting peaks. The total
amount of chitooligosaccharides released to the solution was determined
by using the colorimetric method developed by Dubois et al.16 Briefly,
0.1 mL of the solution was mixed with 0.1 mL of phenol solution (5%
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in water) and with 0.5 mL of concentrated sulfuric acid. The mixture
was equilibrated at 30 °C during 20 min and then the absorbance was
read in a Synergy-HT spectrophotometer (Bio Tek Instruments) at 485
nm. A calibration curve was prepared with the pristine chitooligosac-
charides.
Cytotoxicity was evaluated with a fibroblast cell line using the MTT
assay with the materials’ extracts. Injectable specimens were prepared
as stated previously, except that the solutions were first sterilized
through filtration with a 22 µm sterile filter. The specimens were
polymerized directly inside falcon tubes, after which cell culture
medium was added at a ratio of 0.05 g of material in 5 mL of medium.
The toxicity of methacrylated oligomers was studied by adding the
oligomer solution without activators to the falcon tube. Materials were
left at 37 °C under agitation for 1, 2, and 7 days, being the medium
collected and changed by fresh one at each intermediate period. The
results were compared with chitosan membranes (whose extracts were
obtained in the same manner), negative control (Thermanox) and
positive control (Triton X-100, 0.5% in culture medium). The assay
was then performed as follows: cells were seeded on a 96 well culture
plate and incubated until reaching confluence at a density of 5.5 × 104
cells/mL. The culture medium was then replaced by the eluted extracts
of each material (100 µL/well), and the plate was incubated at 37 °C,
5% CO2, and 24 h. After this period, extracts were removed and ((3-
[4, 5 dimethylthyazol-2-yl])-2,5-diphenyl tetrazolium bromide) (MTT),
dissolved in PBS (0.05% wt/vol), was added to each well (100 µL/
well). The plate was again incubated at 37 °C for 4 h, the MTT solution
was removed and replaced by 100 µL of dimethylsulfoxide (DMSO).
The absorbance of the final solution was read in the Synergy-HT
spectrophotometer (Bio Tek Instruments) at 570 nm.
Results and Discussion
Chitooligosaccharides were used to prepare injectable sys-
tems, instead of chitosan itself, due to several reasons. First,
they are readily soluble in water at any pH, allowing for a higher
number of possible chemical modifications as compared to
chitosan, which is only soluble in acidic conditions. Second,
solutions of oligomers may be prepared at higher concentrations
(up to 20%, depending on the degree of polymerization) while
still keeping low viscosity. Third, oligomers are easier to modify,
and reactions with oligomers proceed faster than reactions with
chitosan due to their reduced molecular weight. Chitooligosac-
charides were prepared by well-established enzymatic depo-
lymerization reactions. Pectinase, a commercially available
enzyme with chitosanase activity and which was shown to
depolymerize chitosan into oligomers with medium to high
degree of polymerization (Dp)17,18 was employed for this
purpose. Figure 1 displays a MALDI-TOF mass spectrum of
the oligomer mixture after 24 h of depolymerization. The major
components of the mixture are chitooligosaccharides with Dp
5-8, with none or only one N-acetylated unit. For our purposes,
it was important to balance full solubility (what requires the
preparation of oligomers with low Dp) with the ability to
incorporate at least two modified units in the oligomer backbone
(what requires oligomers with high Dp). Therefore, depolym-
erization time was adjusted to 17 h, a condition leading to a
100% soluble product and a high fraction of high Dp oligomers.
Low Dp chitooligosaccharides were subsequently removed from
the mixture by fractional precipitation in ethanol.18
Figure 1. MALDI-TOF/MS spectrum of oligomer mixture after 24 h of depolymerization. Each peak corresponds to a fragment with (Dp)(Ac),
where Dp is the degree of polymerization and Ac is the number of acetylated units. The columns on the right list all fragments identified for this
sample.
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The remaining oligomer fraction, with Dp higher than 4
(about 80% of the initial chitosan mass), was then reacted with
methacrylic anhydride in PBS (pH 7.4; see Experimental
Section). The reaction occurs through nucleophilic substitution
at the primary amine, with the release of methacrylic acid to
the reaction medium (see scheme in Figure 2). The degree of
substitution could be easily tailored by controlling reaction
conditions and varied between 5 and 50%. Figure 3 displays
the 1H NMR of both native and modified oligomers, with the
bands attributed to methacrylamide oligomers appearing at 2.15
ppm (R-CH3 group) and 5.7-6.0 ppm (methacrylic double bond
hydrogens). Although our design of experiments indicated that
the temperature has no effect on the degree of substitution (DS),
usually a higher temperature was used to allow easier equilibra-
tion of the system. The product was soluble in water and was
recovered by precipitation in ethanol. Nonetheless, conditions
leading to higher degree of substitution were also favoring the
appearance of a high fraction of insoluble material. This turned
out to be a fraction of oligomers with even higher degree of
substitution (as seen by FTIR; data not shown). Overall, DS on
the range 16-21% were the ideal ones, leading to a yield of
80% relative to the initial oligomer mass (therefore, the final
yield of both steps was about 65% of the initial chitosan mass).
The presence of a polymerizable double bond as a side group
on the chitooligosaccharides backbone allowed the cross-linking
of these oligomers in physiological conditions, either by a redox
initiation or by a photoinitiation system. Irgacure 2959 may be
used for the latter, while sodium persulfate (NaPS) and ascorbic
acid (AA) form a suitable redox pair initiator. Both systems
were shown to be noncytotoxic.19,20 In this work, the redox pair
at concentrations 0.062 M/0.025 M (NaPS/AA) for a solution
of PBS containing 10% (w/v) oligomer was used. The cross-
linking occurs through free radical polymerization of the pendant
methacrylic groups, as shown schematically in Figure 2. This
yielded an injectable system able to gel in 13 min at 37 °C, as
determined by the tube inversion method (TIM). In fact, the
system allowed an easy tailoring of gelling time, as it could be
changed from 1.5 min up to 60 min by changing several factors:
concentration of oligomer in PBS, concentration of the redox
pair, degree of acetylation (DA) of the native oligomer, and
DS of the modified oligomer. The use of methacrylated
chitooligosaccharides has an additional advantage over other
natural or synthetic polymers, because the persulfate reacts
directly with saccharides to produce radicals on the polymer
backbone,21 avoiding the need of AA (more toxic than the
persulfate)19 or allowing for the use of lower amounts of the
NaPS/AA pair. Systems consisting only of oligomer (10% w/v)
and NaPS (0.12 M) were able to gel at 37 °C, supporting this
hypothesis. Although both the initiation and the propagation
steps are exothermic, due to the high water content of the system
only a small increase in temperature (to 39.5 °C) was observed
in the first minute. This increase is most likely due to the
decomposition of the redox pair and should therefore present
no problem because the temperature quickly returns to the
physiological value.
The evolution of viscosity and storage modulus (G′) of the
curing gel was followed by oscillatory rheometry using a parallel
plates configuration, and is shown in Figure 4. During the initial
Figure 2. Scheme showing the methacrylation reaction and the cross-linking mechanism initiated by a redox pair of sodium persulfate/ascorbic
acid.
Figure 3. 1H NMR of chitooligosaccharide (bottom) and three modified
oligomers with different degrees of substitution (DS). The character-
istic bands of each unit in the oligomer backbone are identified: H1(D)
and H2(D) are the protons at the first and second carbons, respec-
tively, of D-glucosamine; CH2(M) are the two vinyl protons of the
methacrylamide-glucosamine; CH3(A) and CH3(M) are the methyl
protons of N-acetyl-glucosamine and methacrylamide-glucosamine,
respectively. The integration values for peaks used to determine DA
and DS are shown. The peak at 5.1 ppm (H1(D)) was given a relative
intensity of 1.0.
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stages of curing, the solution has a very low complex viscosity
(η*), close to that of water (lower than 10 Pa · s). This allows
easy injection through standard needles or even filtration through
filters with pores of 22 µm diameter. Close to the gelling time,
the system still presents a complex viscosity lower than 500
Pa · s, facilitating injection. Although the material does not flow
anymore after this time, it continues to harden, reaching final
values of storage modulus in the range of 4 to 5 kPa, which is
in the range of strong gels and 1 order of magnitude higher
than typical thermogelling or self-assembling systems.7,6,22-24
The material is, therefore, easily injectable, fast gelling, and
strong and cohesive after final hardening.
The curing process was also studied from a molecular point
of view by using oscillatory rheometry. When a cross-linking
polymer is at the gel time (time at which it reaches infinite
molecular weight), the “tan δ” value, as determined from
oscillatory rheometry, is independent of the frequency of
oscillation.25 By rapidly changing the frequency when testing
our materials, we obtained a gel time of 15 min, which is quite
close to the time of no-flow determined by TIM. In fact, it seems
that flow is restricted even before a fully cross-linked polymer
is obtained. Such methodology additionally allowed us to
determine the relaxation exponent n of the equation for the
stiffness of the critical gel.25 The value of n varies from 0 (stiff
critical gel) to 1 (soft gel); our system presented an intermediate
value of 0.53.
The evolution of complex viscosity and gelling time should
be related to the consumption of double bonds from the acrylic
functionality. To confirm that the polymerization of the gel was
followed with 1H NMR (Figure 5) to assess the decrease in the
area of bands associated with acrylic double bonds (5.7 ppm
and 6.0 ppm). Clearly, the conversion proceeds fast in the first
minutes, reaching about 55% after 15 min of polymerization.
Only about half of the incorporated double bonds, therefore,
are required to fully cross-link the polymer if this data is
compared to the ones obtained by rheometry. Due to the increase
in viscosity and decrease in chain mobility, as a consequence
of such widespread cross-linking, conversion increases slowly
up to 30 min (∼62%) and then levels-off, reaching about 68%
after 1 h of polymerization. Nonetheless, and although the
material is already a hardened gel, polymerization proceeds
during the first week, with conversions of up to 76% at 7 days.
This data means that 24% of the acrylic double bonds will
still remain within the gel even after 1 week of polymerization,
which could create potential cytotoxic issues. To evaluate that,
the extracts of injectable hydrogels were added to a fibroblast
cell line for a period of 1 week. Sterilization was performed by
filtration of the oligomer solution, therefore, no subsequent
washing or lag time (besides the time for hardening of the gel)
was needed. This was an important precaution to ensure that
all possibly toxic extractable substance would be assessed.
Moreover, methacrylic functionalized oligomers (without cross-
linking) were also evaluated to verify the noncytotoxicity of
the starting material. After 1 day, the dissolved oligomers
showed no significant difference on cellular viability when
compared to a Thermanox control, confirming that the acrylic
functionality is not cytotoxic. This is probably due to the fact
they are attached to relatively large oligomers (MW 700 g/mol),
in contrast to the small MMA (100.12 g/mol), a toxic acrylate
monomer released from self-curing acrylic bone cements.26,27
Extractables from the hardened gel (activators, unreacted
oligomers, degradable products) were noncytotoxic as well after
up to 7 days. In fact, after the second day of testing, the gel
showed increased cellular viability as compared to the control,
reaching 160% of the values shown by Thermanox after 7 days
(this value was significant with p < 0.05). It seems, therefore,
that the released and degraded acrylated oligomers were
promoting cell multiplication, an effect already demonstrated
for conventional chitooligosaccharides.28 These results outper-
formed prefabricated chitosan membranes, which displayed no
significant difference with the control over the entire period.
Last, degradation of injectable materials was assessed in
solutions containing lysozyme, an enzyme which degrades
chitosan. Degradation solutions were analyzed both by HPLC
and by a colorimetric method.16 While chitosan membranes
showed very slow degradation rate, injectable materials were
quickly degraded since the first week. After 9 weeks, injectable
materials had lost about 28.1% of their initial mass, while
chitosan membranes, under the same conditions, lost only
0.98%. This is probably due to the much higher water content
of the injectable hydrogels, which are composed of 90% water.
It then allows much faster and easier diffusion of the enzyme
into the material, speeding up the process of degradation. A
large amount of chitooligosaccharides was already detected on
the first week (Figure 6), which may explain the higher cellular
viability observed for these materials. It is also important to
Figure 4. Evolution of storage modulus (G′, open symbols) and
complex viscosity (η*, closed symbols) as a function of polymerization
times at two temperatures: 25 °C (squares) and 37 °C (circles).
Figure 5. Evolution of the polymerization, expressed as conversion
of double bonds, followed by in situ polymerization 1H NMR. The
bands at 5.7 and 5.9 ppm corresponds to the vinyl protons; dimethyl
formamide (band at 7.95 ppm) was added as a reference.
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stress that, despite such higher weight loss, the specimens did
not disintegrate, keeping their initial shape and cohesion even
after 80 days of degradation.
Conclusion
An innovative injectable system composed of methacrylic
modified chitooligosaccharides was introduced. The system may
be prepared by an easy route and is able to gel in physiological
conditions in less than 15 min. The gel presents a shear storage
modulus in the kPa range, therefore, being well suited for drug
delivery or soft tissue engineering applications. Degradation and
cytotoxicity behavior outperformed chitosan membranes. In
summary, injectable biodegradable systems based on chitooli-
gosaccharides are interesting materials to be used in the
biomedical field, especially for tissue engineering or drug
delivery systems. They perform as well as other injectable or
prefabricated materials and are additionally almost entirely
composed of biobased polymers. Moreover, their preparation
does not make use of toxic solvents or time-consuming
intermediate steps. This is in clear contrast with the majority
of injectable systems currently being developed and represent
an appealing concept for their scale up and industrial production
once the production process is simple and may be easily adapted
to ensure recovery of byproducts. It may also represent a
valuable alternative for less-favored countries to develop their
own technology, because the materials and processes described
here are cheap and widely available.
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Figure 6. HPLC spectra of degradation products from chitosan
membranes after 9 weeks (dashed line) and injectable material after
1 week (solid line). The peak at 5.7 min corresponds to the lysozyme.
The degradation products of the chitosan injectable are high MW
oligomers (Dp 3; broad peak from 1.8 min to 4.6 min), low MW
oligomers (Dp 3; shoulders at 3.8 min and 4.2 min, peak at 6.9 min),
and the monomers (D-glucosamine at 3.0 min and N-acetyl glu-
cosamine at 3.2 min).
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